The impact of vitamin D deficiency on diabetes and cardiovascular risk

Orwoll, 2009, Vitamin D deficiency in older men, J Clin Endocrinol Metab, 94, 1214, 10.1210/jc.2008-1784

Kumar, 2009, Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004, Pediatrics, 124, e362, 10.1542/peds.2009-0051

Holick, 2007, Vitamin D deficiency, N Engl J Med, 357, 266, 10.1056/NEJMra070553

Hypponen, 2007, Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors, Am J Clin Nutr, 85, 860, 10.1093/ajcn/85.3.860

Hagenau, 2009, Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis, Osteoporos Int, 20, 133, 10.1007/s00198-008-0626-y

Ginde, 2009, Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004, Arch Intern Med, 169, 626, 10.1001/archinternmed.2008.604

Bertoni, 2002, Diabetes-related morbidity and mortality in a national sample of U.S. elders, Diabetes Care, 25, 471, 10.2337/diacare.25.3.471

Zimmet, 2001, Global and societal implications of the diabetes epidemic, Nature, 414, 782, 10.1038/414782a

Fang, 2006, Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990–2000, Diabetes, 55, 768, 10.2337/diabetes.55.03.06.db05-1196

Martins, 2007, Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey, Arch Intern Med, 167, 1159, 10.1001/archinte.167.11.1159

Wang, 2008, Vitamin D deficiency and risk of cardiovascular disease, Circulation, 117, 503, 10.1161/CIRCULATIONAHA.107.706127

Kim, 2008, Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004), Am J Cardiol, 102, 1540, 10.1016/j.amjcard.2008.06.067

Nagpal, 2005, Noncalcemic actions of vitamin D receptor ligands, Endocr Rev, 26, 662, 10.1210/er.2004-0002

Norman, 2006, Minireview: vitamin D receptor: new assignments for an already busy receptor, Endocrinology, 147, 5542, 10.1210/en.2006-0946

Townsend, 2005, Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment, J Steroid Biochem Mol Biol, 97, 103, 10.1016/j.jsbmb.2005.06.004

Bischoff-Ferrari, 2006, Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes, Am J Clin Nutr, 84, 18, 10.1093/ajcn/84.1.18

Vieth, 2007, The urgent need to recommend an intake of vitamin D that is effective, Am J Clin Nutr, 85, 649, 10.1093/ajcn/85.3.649

Holick, 2005, Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy, J Clin Endocrinol Metab, 90, 3215, 10.1210/jc.2004-2364

Bischoff-Ferrari, 2005, Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials, JAMA, 293, 2257, 10.1001/jama.293.18.2257

Broe, 2007, A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study, J Am Geriatr Soc, 55, 234, 10.1111/j.1532-5415.2007.01048.x

Mathieu, 1994, Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3, Diabetologia, 37, 552, 10.1007/BF00403372

Littorin, 2006, Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS), Diabetologia, 49, 2847, 10.1007/s00125-006-0426-x

1999, The EURODIAB Substudy 2 Study Group., Diabetologia, 42, 51

Hypponen, 2001, Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study, Lancet, 358, 1500, 10.1016/S0140-6736(01)06580-1

Pitocco, 2006, The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI), Diabet Med, 23, 920, 10.1111/j.1464-5491.2006.01921.x

Pittas, 2007, The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis, J Clin Endocrinol Metab, 92, 2017, 10.1210/jc.2007-0298

Chiu, 2004, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction, Am J Clin Nutr, 79, 820, 10.1093/ajcn/79.5.820

Need, 2005, Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women, Clin Endocrinol (Oxf), 62, 738, 10.1111/j.1365-2265.2005.02288.x

Hypponen, 2006, Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity, Diabetes Care, 29, 2244, 10.2337/dc06-0946

Targher, 2006, Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients, Clin Endocrinol (Oxf), 65, 593, 10.1111/j.1365-2265.2006.02633.x

Scragg, 2004, Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey, Diabetes Care, 27, 2813, 10.2337/diacare.27.12.2813

Mattila, 2007, Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes, Diabetes Care, 30, 2569, 10.2337/dc07-0292

Forouhi, 2008, Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000, Diabetes, 57, 2619, 10.2337/db08-0593

Fliser, 1997, No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects, Eur J Clin Invest, 27, 629, 10.1046/j.1365-2362.1997.1520699.x

Borissova, 2003, The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients, Int J Clin Pract, 57, 258, 10.1111/j.1742-1241.2003.tb10480.x

Pittas, 2007, The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults, Diabetes Care, 30, 980, 10.2337/dc06-1994

de Boer, 2008, Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative, Diabetes Care, 31, 701, 10.2337/dc07-1829

Macdonald, 2008, Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D, Bone, 42, 996, 10.1016/j.bone.2008.01.011

Konradsen, 2008, Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index, Eur J Nutr, 47, 87, 10.1007/s00394-008-0700-4

Ford, 2005, Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults, Diabetes Care, 28, 1228, 10.2337/diacare.28.5.1228

Wortsman, 2000, Decreased bioavailability of vitamin D in obesity, Am J Clin Nutr, 72, 690, 10.1093/ajcn/72.3.690

Sneve, 2008, Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects, Eur J Endocrinol, 159, 675, 10.1530/EJE-08-0339

Major, 2009, Calcium plus vitamin D supplementation and fat mass loss in female very low-calcium consumers: potential link with a calcium-specific appetite control, Br J Nutr, 101, 659, 10.1017/S0007114508030808

Grundy, 2004, Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6

Ford, 2008, Metabolic syndrome and incident diabetes: current state of the evidence, Diabetes Care, 31, 1898, 10.2337/dc08-0423

Reis, 2008, Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults, Eur J Endocrinol, 159, 41, 10.1530/EJE-08-0072

Hypponen, 2008, 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort, Diabetes, 57, 298, 10.2337/db07-1122

McGill, 2008, Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity, Nutr J, 7, 4, 10.1186/1475-2891-7-4

Kabakov, 2006, Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors, J Cardiometab Syndr, 1, 95, 10.1111/j.1559-4564.2006.05513.x

Li, 2002, 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system, J Clin Invest, 110, 229, 10.1172/JCI0215219

Zhou, 2008, Calcium-independent and 1,25(OH)2D3-dependent regulation of the rennin–angiotensin system in 1alpha-hydroxylase knockout mice, Kidney Int, 74, 170, 10.1038/ki.2008.101

Kristal-Boneh, 1997, Association of calcitriol and blood pressure in normotensive men, Hypertension, 30, 1289, 10.1161/01.HYP.30.5.1289

Lind, 1995, Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men, Am J Hypertens, 8, 894, 10.1016/0895-7061(95)00154-H

Forman, 2007, Plasma 25-hydroxyvitamin D levels and risk of incident hypertension, Hypertension, 49, 1063, 10.1161/HYPERTENSIONAHA.107.087288

Pfeifer, 2001, Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women, J Clin Endocrinol Metab, 86, 1633

Margolis, 2008, Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial, Hypertension, 52, 847, 10.1161/HYPERTENSIONAHA.108.114991

Scragg, 1990, Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study, Int J Epidemiol, 19, 559, 10.1093/ije/19.3.559

Kendrick, 2009, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey, Atherosclerosis, 205, 255, 10.1016/j.atherosclerosis.2008.10.033

Giovannucci, 2008, 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study, Arch Intern Med, 168, 1174, 10.1001/archinte.168.11.1174

Dobnig, 2008, Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality, Arch Intern Med, 168, 1340, 10.1001/archinte.168.12.1340

Thompson, 2005, Update on using coronary calcium screening by computed tomography to measure risk for coronary heart disease, Int J Cardiovasc Imaging, 21, 39, 10.1007/s10554-004-5343-9

Dendukuri, 2007, Validity of electron beam computed tomography for coronary artery disease: asystematic review and meta-analysis, BMC Med, 5, 35, 10.1186/1741-7015-5-35

Watson, 1997, Active serum vitamin D levels are inversely correlated with coronary calcification, Circulation, 96, 1755, 10.1161/01.CIR.96.6.1755

Need, 2000, Vitamin D status: effects on parathyroid hormone and 1, 25-dihydroxyvitamin D in postmenopausal women, Am J Clin Nutr, 71, 1577, 10.1093/ajcn/71.6.1577

Hsia, 2007, Calcium/vitamin D supplementation and cardiovascular events, Circulation, 115, 846, 10.1161/CIRCULATIONAHA.106.673491

Farmer, 2000, Renin angiotensin system and ASCVD, Curr Opin Cardiol, 15, 141, 10.1097/00001573-200005000-00004

Milliez, 2005, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism, J Am Coll Cardiol, 45, 1243, 10.1016/j.jacc.2005.01.015

Achinger, 2005, The role of vitamin D in left ventricular hypertrophy and cardiac function., Kidney Int Suppl, S37, 10.1111/j.1523-1755.2005.09506.x

Merke, 1987, Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro, Calcif Tissue Int, 41, 112, 10.1007/BF02555253

Cardus, 2006, 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway, Kidney Int, 69, 1377, 10.1038/sj.ki.5000304

Carthy, 1989, 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth, Hypertension, 13, 954, 10.1161/01.HYP.13.6.954

Somjen, 2005, 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds, Circulation, 111, 1666, 10.1161/01.CIR.0000160353.27927.70

Koenig, 1999, C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992, Circulation, 99, 237, 10.1161/01.CIR.99.2.237

Amento, 1987, Vitamin D and the immune system, Steroids, 49, 55, 10.1016/0039-128X(87)90079-1

Shoelson, 2006, Inflammation and insulin resistance, J Clin Invest, 116, 1793, 10.1172/JCI29069

Cohen-Lahav, 2007, The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages, J Steroid Biochem Mol Biol, 103, 558, 10.1016/j.jsbmb.2006.12.093

Cohen-Lahav, 2006, Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels, Nephrol Dial Transplant, 21, 889, 10.1093/ndt/gfi254

Talmor, 2008, Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro, Eur J Clin Invest, 38, 548, 10.1111/j.1365-2362.2008.01977.x

Oh, 2009, 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus, Circulation, 120, 687, 10.1161/CIRCULATIONAHA.109.856070

Jacobus, 1992, Hypervitaminosis D associated with drinking milk, N Engl J Med, 326, 1173, 10.1056/NEJM199204303261801

Koutkia, 2001, Vitamin D intoxication associated with an over-the-counter supplement, N Engl J Med, 345, 66, 10.1056/NEJM200107053450115

Klontz, 2007, Dietary supplement-induced vitamin D intoxication, N Engl J Med, 357, 308, 10.1056/NEJMc063341

Mocanu, 2009, Long-term effects of giving nursing home residents bread fortified with 125 microg (5000 IU) vitamin D(3) per daily serving, Am J Clin Nutr, 89, 1132, 10.3945/ajcn.2008.26890

Hathcock, 2007, Risk assessment for vitamin D, Am J Clin Nutr, 85, 6, 10.1093/ajcn/85.1.6